Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch
Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. A look at what 2024 might have in store.
Source: cnbc.com
Page 18 - Michael Yee News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Michael Yee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Michael Yee Today - Breaking & Trending Today
Vertex Stock Is Jumping as Data Raise Hope for a Pain Pill Blockbuster
Vertex disclosed promising test results for a drug that could offer an alternative to opioids.
Source: marketwatch.com
Where M&A could be heading in the obesity drug space
Investors are contemplating where and when the next big obesity drug deal will occur.
Source: cnbc.com
Vertex shares pop after nonopioid painkiller posts positive midstage trial results
The results support Vertex’s hopes of developing a drug that can provide strong pain relief without the addictive potential of opioid medications.
Source: nbcphiladelphia.com